Last reviewed · How we verify
NCT06878807
Exploring the Role of Working Memory Saturation in Eye Movement Desensitization and Reprocessing (EMDR) Using the Eye Blink Conditioning Paradigm
NA trial testing eye movement in Eye Movement Desensitization and Reprocessing in 112 participants. Completed in 1 April 2025.
1 December 2024
Quick facts
| Lead sponsor | Hospital Clinic of Barcelona |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 112 |
| Start date | 1 April 2022 |
| Primary completion | 1 December 2024 |
| Estimated completion | 1 April 2025 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- eye movement
- TMT-B
Conditions studied
- Eye Movement Desensitization and Reprocessing — all drugs for Eye Movement Desensitization and Reprocessing →
Sponsor
Hospital Clinic of Barcelona
Who can join
Adults 18 to 65, any sex, with Eye Movement Desensitization and Reprocessing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Eye Movement Desensitization and Reprocessing (EMDR) is a well-established, evidence-based treatment for posttraumatic stress disorder (PTSD). It is endorsed by leading organizations such as the American Psychiatric Association and the World Health Organization. During EMDR therapy, patients focus on recalling traumatic events while simultaneously engaging with an external stimulus. Specifically, patients undergo lateral eye movements. This process is believed to reduce the vividness and emotional intensity of traumatic memories by addressing and desensitizing their cognitive, emotional, and physical components. Despite its proven efficacy in treating PTSD, the precise mechanisms underlying these therapeutic effects remain not fully understood. Several hypotheses have been proposed to explain the efficacy of EMDR. Among them, the working memory hypothesis is particularly influential and is supported by a substantial body of research. This hypothesis suggests that aversive memories and fear, when recalled, occupy limited memory resources. Therefore, performing a task, such as eye movements, during the recall of the traumatic experience would result in a competition for limited memory resources, leading to a decrease in the vividness and emotional intensity of the traumatic memory. Consequently, the dual task inherent in EMDR is thought to facilitate a rapid elimination of the emotional responses triggered by the traumatic memory, allowing patients to alleviate the physical and psychological distress associated with the trauma. Measuring the effects of an EM intervention through a standardized protocol could clarify the conditions under which the intervention is most effective and elucidate the potential mechanisms of EMDR. In this context, the Eye Blink Conditioning (EBC) task, a well-established and standardized conditioning paradigm, seems relevant for testing the working memory hypothesis. In the EBC task, eyelid closure is measured in response to a corneal air puff, which acts as the unconditioned stimulus. The unconditioned stimulus is paired with a neutral stimulus, a tone, which becomes a conditioned stimulus by eliciting a conditioned response similar to that produced by the unconditioned stimulus. After the conditioning phase, participants undergo the extinction phase. In this phase, the conditioned stimulus is presented without the unconditioned stimulus for many trials, and the main objective is to measure how many trials it takes for the participants to eliminate the previous associative learning between the aversive stimulus (air puff) and the conditioned stimulus (tone). This study aimed to explore whether the effectiveness of a straightforward eye movement intervention in accelerating extinction is influenced by the working memory hypothesis. The hypothesis is that the enhancement of extinction learning is dependent on working memory saturation. Understanding the role of working memory saturation in the effectiveness of eye movements during extinction learning could provide critical insights into the working memory hypothesis as a potential key mechanism underlying the efficacy of EMDR therapy.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06878807
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Eye Movement Desensitization and Reprocessing
Currently open trials in the same condition.
- NCT06767332 — EMDR for Fear of Cancer Recurrence in Patients with Familial Melanoma: a Waiting List Control Trial · NA · recruiting
- NCT04672551 — EMDR Treatment in PTSD Following Cardiac Events · NA · recruiting
Other Hospital Clinic of Barcelona trials
Trials by the same sponsor.
- NCT07509814 — Extended Versus Short Prehabilitation Programme for Patients With Advanced Ovarian Cancer Undergoing Major Surgery · NA · not yet recruiting
- NCT07469358 — iCBT for Adolescents Obsessive-compulsive Dissorder · NA · active not recruiting
- NCT07358611 — Non-invasive Mapping-Guided Atrial Fibrillation Ablation · NA · recruiting
- NCT07237867 — Frequency-Dependent Effects of Percutaneous Femoral Nerve Stimulation on Quadriceps Strength in Athletes With Patellar T · NA · recruiting
- NCT07163936 — Analysis of the Influence of Dialysis Fluid Composition on Vascular Calcification in Patients With Chronic Kidney Diseas · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06878807 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Clinic of Barcelona
- Last refreshed: 16 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06878807.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing